Targeted breast cancer radiotherapy reduces side effects
Targeted radiotherapy on the site where tumours first develop rather than to the whole breast can dramatically reduce side effects for breast cancer patients, a trial shows.
Targeted radiotherapy on the site where tumours first develop can dramatically reduce side effects for breast cancer patient, a new trial shows.
Researchers at 30 centres across the UK studied 2,000 women aged 50 or over who had early stage breast cancer identified as at a low risk of returning.
Some were treated with whole breast radiotherapy – the clinical standard – while others received partial radiotherapy specifically at the site of the tumour. Patients in both groups received 15 sessions of treatment over a three-week period.
and 1 in 870 men will be diagnosed with
Want to read more?
Unlock full access to RCNi Plus today
Save over 50% on your first three months:
- Customisable clinical dashboard featuring 200+ topics
- Unlimited online access to all 10 RCNi Journals including Nursing Standard
- RCNi Learning featuring 180+ RCN accredited learning modules
- NMC-compliant RCNi Portfolio to build evidence for revalidation
- Personalised newsletters tailored to your interests